Built industry's first enterprise biospecimen, digital specimen, and consent management organization. Led high-performing team of 100+ to support entire clinical portfolio and Discovery labs, while successfully launching new process and technology infrastructure. Devised framework for Human Tissue Policy and governance structure. Formulated digital specimen roadmap. Led development of China HGRAC Operations and Regulatory Task Force recommendations. Advisor to Clinical Automation Digital Data Workflow team.

Building bridges between compound management and profiling and biospecimen management and profiling, to learn from one another to expedite trials and research, to benefit patients.

Started as Lead SME in Clinical Genomics for IT; within two years was elevated to Site Head of 3 sites and asked to design an organization and lead team of 16 through the Schering- Plough merger. Responsible for meeting the IT needs of 7 franchises and 6 departments (>1,200 scientists) encompassing all therapeutic areas and biomarker groups at Merck. Managed relationships with senior executives and acted as strategic partner to implement technology to enable research. Responsible for operational support of 20+ Discovery & Preclinical Science programs to ensure pipeline goals were met. Started as Lead SME in Clinical Genomics for IT; within two years was elevated to Site Head of 3 sites and asked to design an organization and lead team of 16 through the Schering- Plough merger. Responsible for meeting the IT needs of 7 franchises and 6 departments (>1,200 scientists) encompassing all therapeutic areas and biomarker groups at Merck. Managed relationships with senior executives and acted as strategic partner to implement technology to enable research. Responsible for operational support of 20+ Discovery & Preclinical Science programs to ensure pipeline goals were met.

Client -facing senior leader responsible for driving global strategy and innovation for specimen management and biorepository practices at the world’s second largest Central Lab. Led a global team of ~270 people across 3 major sites and 8 ancillary sites. Identified new services as key differentiator in the CRO market. Thought leader on “Lab of the Future” to support the evolving clinical trial environment.

Advised senior science, operations, and informatics executives as to opportunities to innovate the clinical development space as it pertained to Precision Medicine goals. Developed an innovation operating model; worked with clinical teams to improve clinical specimen management to support biomarker and diagnostic development by operationalizing Precision Medicine via policy, process, and infrastructure recommendations. Examined uses of artificial intelligence within the clinical development space. As Business Process Owner for Specimen Management, responsible for specimens in over 600 global clinical trials, plus legacy collections. Designed Biospecimen Operations organization to support clinical trial teams.